Nilogen Oncosystems Revenue and Competitors

Orlando, FL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nilogen Oncosystems's estimated annual revenue is currently $2.3M per year.(i)
  • Nilogen Oncosystems's estimated revenue per employee is $155,000

Employee Data

  • Nilogen Oncosystems has 15 Employees.(i)
  • Nilogen Oncosystems grew their employee count by 0% last year.

Nilogen Oncosystems's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
VP Business DevelopmentReveal Email/Phone
4
Director ResearchReveal Email/Phone
5
Lead HistotechnologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is Nilogen Oncosystems?

Nilogen Oncosystems is dedicated to streamlining and improving drug development in cancer and immuno-oncology. At Nilogen, we appreciate the complexity of cancer and use fresh patient tumor samples with intact tumor immune microenvironment in our preclinical drug testing platforms. This allows us to see the whole picture for a better understanding of the molecular mechanisms of drug sensitivity and resistance. These proprietary and innovative platforms aim to significantly reduce the cost and risk associated with clinical trials. Nilogen’s commitment to testing and customizing cancer drug development is proven and yields unparalleled results for its clients.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M15-6%N/A
#2
$2.7M15-6%N/A
#3
$0.4M15-21%$4.2M
#4
$1.3M15-46%N/A
#5
$1.6M1515%N/A